Compugen (CGEN) Interest & Investment Income (2009 - 2015)
Compugen's (CGEN) quarterly Interest & Investment Income came in at $500000.0 in Q3 2015, down 70.06% year-on-year from $1.7 million in Q3 2014, and down 70.06% quarter-over-quarter from $1.7 million in Q3 2014.
Compugen (CGEN) Interest & Investment Income (2009 - 2015) Analysis & Trends
Compugen has disclosed Interest & Investment Income across 7 years of filings, most recently posting $500000.0 for Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 500,000.00 |
| Sep 30, 2014 | 1.67 Mn |
| Jun 30, 2014 | 2.47 Mn |
| Jun 30, 2013 | 2.27 Mn |
| Jun 30, 2012 | 2.33 Mn |
| Jun 30, 2011 | 1.51 Mn |
| Sep 30, 2010 | 352,000.00 |
| Jun 30, 2010 | 41,000.00 |
| Sep 30, 2009 | 217,000.00 |
| Jun 30, 2009 | 279,000.00 |